EST
EW icon

EA Series Trust’s Edwards Lifesciences EW Stock Holding History

EA Series Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$399K Buy
+4,235
New +$368K 0.01% 886

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

EA Series Trust's EW Position: Q2 2023 in Review

EA Series Trust opened a new position in Edwards Lifesciences (EW) in Q2 2023: 4,235 shares worth $399K. The stake represents 0.01% of the portfolio and ranks #886 among its holdings.

1,278 funds tracked by Wall St. Rank hold EW as of Q2 2023.

  • EA Series Trust held 4,235 shares of Edwards Lifesciences worth $399K as of Q2 2023.
  • Edwards Lifesciences was a new EA Series Trust position in Q2 2023.
  • Edwards Lifesciences made up 0.01% of EA Series Trust's portfolio in Q2 2023, its #886 holding.
  • 1,278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.